Filters

Claire Mounier-Vehier, Michel Azizi, Pierre-Yves Courand, Thierry Denolle, Pascal Delsart, Valentina Zhygalina, Laurence Amar, Pierre Lantelme, Nadia De Mota, Fabrice Balavoine, Catherine Llorens-Cortes

Journal of hypertension 2020;37(8):1722-1728

Full Text

Abstract

Results: 1 – 8 / 8

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Glutamyl Aminopeptidase""[mesh_terms]

Firibastat: a Novel Treatment for Hypertension.

Biochemical and enzymatic properties of the M1 family of aminopeptidases involved in the regulation of blood pressure.

Stereospecificity of alpha-proton exchange reactions catalysed by pyridoxal-5'-phosphate-dependent enzymes.

Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins.

Aminopeptidases in Cardiovascular and Renal Function. Role as Predictive Renal Injury Biomarkers.

Safety, tolerability and pharmacokinetics of oral S-3304, a novel matrix metalloproteinase inhibitor, in single and multiple dose escalation studies in healthy volunteers.

Future pharmacological therapy in hypertension.

A pilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertension.

Results for
""Glutamyl Aminopeptidase""[mesh_terms]